WW News and Press, WW International Inc. From 01/18/24

2024-01-18 10:47:37 ET More on Consumer Discretionary Select Sector SPDR ETF XLY: Consumer Discretionary Dashboard For December Wall Street Breakfast Catalyst Watch: Is Consumer Sentiment Just Another Data Point In The Mix? Here are top Seeking Alpha Quant picks in C...

2024-01-16 14:04:00 ET Shares of WW International (NASDAQ: WW) , the parent of WeightWatchers, were falling again today as concerns about pressure from GLP-1 drugs like Ozempic continue to push the stock lower. The catalyst for today's slide seemed to be a short report from Cedar Gr...

2024-01-16 11:08:14 ET More on Consumer Discretionary Select Sector SPDR ETF XLY: Consumer Discretionary Dashboard For December Wall Street Breakfast Catalyst Watch: Is Consumer Sentiment Just Another Data Point In The Mix? XLY: Consumer Discretionary Dashboard For O...

NEW YORK, Jan. 16, 2024 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ: WW), (“WeightWatchers,” “WW,” or the “Company”) today announced the findings of its “ Beyond Hunger: Understanding Food Noise ” report focusing on people living with...

2024-01-12 17:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-01-11 18:21:27 ET One stock that's having a hard time in these early days of 2024 is WW International (NASDAQ: WW) , whose money asset is the famous Weight Watchers diet program. On Thursday, the company's shares took another body blow, closing nearly 8% lower on the back of a ...

2024-01-11 16:49:58 ET Summary LifeMD expects a 38% increase in revenues for 2024, driven by its new telehealth operation for GLP-1 obesity drugs. Despite this, the stock is down significantly due to concerns over Eli Lilly direct marketing its GLP-1 obesity drugs. These fears are...

2024-01-11 11:16:04 ET More on Consumer Discretionary Select Sector SPDR ETF XLY: Consumer Discretionary Dashboard For December Wall Street Breakfast Catalyst Watch: Is Consumer Sentiment Just Another Data Point In The Mix? XLY: Consumer Discretionary Dashboard For O...

2024-01-11 01:11:13 ET Summary WW International, Inc. has underperformed the S&P 500 by 98% over the past three years. The company's narrow business model focused on weight loss and weight management may limit its growth potential. WW has significant debt and poor financia...

2024-01-10 08:30:36 ET NetworkNewsWire Editorial Coverage New York, NY – January 10, 2024 – On Sept. 20, 2019, history was made when the U.S. Food and Drug Administration approved Rybelsus as the first oral glucagon-like peptide-1 (GLP-1) agonist for type 2 dia...